NGDI (NEXT GENERATION DIAGNOSTIC INSTRUMENT)— 510(k) K040913

Substantially Equivalent

Bausch & Lomb

FDA 510(k) clearance K040913 for NGDI (NEXT GENERATION DIAGNOSTIC INSTRUMENT), Substantially Equivalent on 2004-07-23. Applicant: Bausch & Lomb.

Clearance details

Applicant: Bausch & Lomb
Product code: Code MXK
Advisory panel: Ophthalmic
Date received: 2004-04-08
Decision date: 2004-07-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Dimas, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.